array(40) {
  [0]=>
  string(4) "2575"
  ["article_id"]=>
  string(4) "2575"
  [1]=>
  string(78) "Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease"
  ["article_title"]=>
  string(78) "Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease"
  [2]=>
  string(150) "Patients treated with mirikizumab in the SERENITY Phase 2 study achieved significant reductions in clinical and endoscopic measures of disease activit"
  ["short_description"]=>
  string(150) "Patients treated with mirikizumab in the SERENITY Phase 2 study achieved significant reductions in clinical and endoscopic measures of disease activit"
  [3]=>
  string(599) "
Patients treated with mirikizumab in the SERENITY Phase 2 study achieved significant reductions in clinical and endoscopic measures of disease activity at 12 weeks compared to placebo. The 
&#nl
The post Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(599) "
Patients treated with mirikizumab in the SERENITY Phase 2 study achieved significant reductions in clinical and endoscopic measures of disease activity at 12 weeks compared to placebo. The 
&#nl
The post Lilly’s Mirikizumab succeeds in phase 2 study in Crohn’s disease appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(115) "https://www.pharmaceutical-business-review.com/news/lillys-mirikizumab-succeeds-in-phase-2-study-in-crohns-disease/"
  ["blog_url"]=>
  string(115) "https://www.pharmaceutical-business-review.com/news/lillys-mirikizumab-succeeds-in-phase-2-study-in-crohns-disease/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:59"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2574"
  ["article_id"]=>
  string(4) "2574"
  [1]=>
  string(52) "Merck to buy Peloton Therapeutics in £1.72bn deal"
  ["article_title"]=>
  string(52) "Merck to buy Peloton Therapeutics in £1.72bn deal"
  [2]=>
  string(157) "Under the deal, Merck’s subsidiary will purchase all outstanding shares of Peloton in exchange for an upfront payment of $1.05bn (£825m) in cash. T"
  ["short_description"]=>
  string(157) "Under the deal, Merck’s subsidiary will purchase all outstanding shares of Peloton in exchange for an upfront payment of $1.05bn (£825m) in cash. T"
  [3]=>
  string(539) "
Under the deal, Merck’s subsidiary will purchase all outstanding shares of Peloton in exchange for an upfront payment of $1.05bn (£825m) in cash. The shareholders of Peloton will 
&#nl
The post Merck to buy Peloton Therapeutics in £1.72bn deal appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(539) "
Under the deal, Merck’s subsidiary will purchase all outstanding shares of Peloton in exchange for an upfront payment of $1.05bn (£825m) in cash. The shareholders of Peloton will 
&#nl
The post Merck to buy Peloton Therapeutics in £1.72bn deal appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(79) "https://www.pharmaceutical-business-review.com/news/merck-peloton-therapeutics/"
  ["blog_url"]=>
  string(79) "https://www.pharmaceutical-business-review.com/news/merck-peloton-therapeutics/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:59"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2573"
  ["article_id"]=>
  string(4) "2573"
  [1]=>
  string(83) "WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract"
  ["article_title"]=>
  string(83) "WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract"
  [2]=>
  string(150) "WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology (stock code 603718.SH). The b"
  ["short_description"]=>
  string(150) "WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology (stock code 603718.SH). The b"
  [3]=>
  string(622) "
WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology (stock code 603718.SH). The business model of WuXi Vaccines is 
&#nl
The post WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract appeared first on Pharmaceutical Business review.
&#nl"
  ["description"]=>
  string(622) "
WuXi Vaccines is a joint venture company to be established between WuXi Biologics and Shanghai based Hile Bio-Technology (stock code 603718.SH). The business model of WuXi Vaccines is 
&#nl
The post WuXi Biologics signed letter of intent for long-term vaccine manufacturing contract appeared first on Pharmaceutical Business review.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "30"
  ["rss_id"]=>
  string(2) "30"
  [14]=>
  string(136) "https://www.pharmaceutical-business-review.com/news/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract/"
  ["blog_url"]=>
  string(136) "https://www.pharmaceutical-business-review.com/news/wuxi-biologics-signed-letter-of-intent-for-long-term-vaccine-manufacturing-contract/"
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:23:59"
  ["create_at"]=>
  string(19) "2019-05-23 14:23:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2349"
  ["article_id"]=>
  string(4) "2349"
  [1]=>
  string(72) "EFAS international conference (autonomic nervous system)  9-10 May, 2019"
  ["article_title"]=>
  string(72) "EFAS international conference (autonomic nervous system)  9-10 May, 2019"
  [2]=>
  string(150) "The conference will include: an Autonomic School providing those starting in the autonomic field with a quick and efficient starter course. (EFAS accr"
  ["short_description"]=>
  string(150) "The conference will include: an Autonomic School providing those starting in the autonomic field with a quick and efficient starter course. (EFAS accr"
  [3]=>
  string(421) "The conference will include: an Autonomic School providing those starting in the autonomic field with a quick and efficient starter course. (EFAS accreditation) The conference focuses on CLINICAL APPLICATION of autonomic knowledge , particularly in the field of TRANSIENT LOSS of CONSCIOUSNESS, and AUTOMATIC DISORDERS in MOVEMENT DISORDERS.&#nl&#nlTarget groups: neurologists, cardiologists, internists and geriatricians"
  ["description"]=>
  string(421) "The conference will include: an Autonomic School providing those starting in the autonomic field with a quick and efficient starter course. (EFAS accreditation) The conference focuses on CLINICAL APPLICATION of autonomic knowledge , particularly in the field of TRANSIENT LOSS of CONSCIOUSNESS, and AUTOMATIC DISORDERS in MOVEMENT DISORDERS.&#nl&#nlTarget groups: neurologists, cardiologists, internists and geriatricians"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(117) "
https://www.pharmiweb.com/event/efas-international-conference-autonomic-nervous-system-9-10-may-2019                "
  ["blog_url"]=>
  string(117) "
https://www.pharmiweb.com/event/efas-international-conference-autonomic-nervous-system-9-10-may-2019                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2348"
  ["article_id"]=>
  string(4) "2348"
  [1]=>
  string(46) "Pharmacovigilance QMS & Inspection Preparation"
  ["article_title"]=>
  string(46) "Pharmacovigilance QMS & Inspection Preparation"
  [2]=>
  string(159) "Course overview&#nl&#nlSince the introduction of the new pharmacovigilance legislation in the EU, Quality Management Systems (QMS)&#nland self-audits have beco"
  ["short_description"]=>
  string(159) "Course overview&#nl&#nlSince the introduction of the new pharmacovigilance legislation in the EU, Quality Management Systems (QMS)&#nland self-audits have beco"
  [3]=>
  string(518) "Course overview&#nl&#nlSince the introduction of the new pharmacovigilance legislation in the EU, Quality Management Systems (QMS)&#nland self-audits have become a hot and growing topic. Companies have been increasingly challenged by regulators to implement risk-based audits where con- tinual improvement of processes, systems and compliance to regulations needs to be demonstrated. This is required from the top of the company organisation in all areas of regulatory activity from clinical, regulatory; p…"
  ["description"]=>
  string(518) "Course overview&#nl&#nlSince the introduction of the new pharmacovigilance legislation in the EU, Quality Management Systems (QMS)&#nland self-audits have become a hot and growing topic. Companies have been increasingly challenged by regulators to implement risk-based audits where con- tinual improvement of processes, systems and compliance to regulations needs to be demonstrated. This is required from the top of the company organisation in all areas of regulatory activity from clinical, regulatory; p…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(93) "
https://www.pharmiweb.com/event/pharmacovigilance-qms-inspection-preparation                "
  ["blog_url"]=>
  string(93) "
https://www.pharmiweb.com/event/pharmacovigilance-qms-inspection-preparation                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2347"
  ["article_id"]=>
  string(4) "2347"
  [1]=>
  string(63) "Development of Drug/Device and Device/Drug Combination Products"
  ["article_title"]=>
  string(63) "Development of Drug/Device and Device/Drug Combination Products"
  [2]=>
  string(156) "What this course is about&#nl&#nlDrug/device and device/drug combination products are becoming increasingly important in the medical industry. The "
  ["short_description"]=>
  string(156) "What this course is about&#nl&#nlDrug/device and device/drug combination products are becoming increasingly important in the medical industry. The "
  [3]=>
  string(520) "What this course is about&#nl&#nlDrug/device and device/drug combination products are becoming increasingly important in the medical industry. The development of these products raises a number of complex issues regarding the development process and their manufacture. The quality and regulatory aspects to consider are also challenging. This seminar will clarify the EU and US approach to drug/device and device/drug combination products. It will discuss the requirements for the Device Technical Fi…"
  ["description"]=>
  string(520) "What this course is about&#nl&#nlDrug/device and device/drug combination products are becoming increasingly important in the medical industry. The development of these products raises a number of complex issues regarding the development process and their manufacture. The quality and regulatory aspects to consider are also challenging. This seminar will clarify the EU and US approach to drug/device and device/drug combination products. It will discuss the requirements for the Device Technical Fi…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(110) "
https://www.pharmiweb.com/event/development-of-drugdevice-and-devicedrug-combination-products                "
  ["blog_url"]=>
  string(110) "
https://www.pharmiweb.com/event/development-of-drugdevice-and-devicedrug-combination-products                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2346"
  ["article_id"]=>
  string(4) "2346"
  [1]=>
  string(55) "Highly Potent Active Pharmaceutical Ingredients (HPAPI)"
  ["article_title"]=>
  string(55) "Highly Potent Active Pharmaceutical Ingredients (HPAPI)"
  [2]=>
  string(150) "The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in developmen"
  ["short_description"]=>
  string(150) "The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in developmen"
  [3]=>
  string(516) "The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.&#nl&#nlThe event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manu…"
  ["description"]=>
  string(516) "The HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.&#nl&#nlThe event will explore current market trends, challenges of correctly assessing hazard, the use of innovative containment solutions to minimize risk and advanced manu…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(102) "
https://www.pharmiweb.com/event/highly-potent-active-pharmaceutical-ingredients-hpapi                "
  ["blog_url"]=>
  string(102) "
https://www.pharmiweb.com/event/highly-potent-active-pharmaceutical-ingredients-hpapi                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2345"
  ["article_id"]=>
  string(4) "2345"
  [1]=>
  string(47) "Highly Potent Active Pharmaceutical Ingredients"
  ["article_title"]=>
  string(47) "Highly Potent Active Pharmaceutical Ingredients"
  [2]=>
  string(156) "SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.&#nl&#nlTh"
  ["short_description"]=>
  string(156) "SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.&#nl&#nlTh"
  [3]=>
  string(520) "SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.&#nl&#nlThe HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.&#nl&#nlThe event will e…"
  ["description"]=>
  string(520) "SMi is delighted to announce its 3rd Annual Highly Potent Active Pharmaceutical Ingredients conference coming to London on the 13th-14th May 2019.&#nl&#nlThe HPAPI global market has developed rapidly in the past year and is continuing to expand into the future, with over a quarter of drugs in development worldwide being classified as highly potent. As a result, there is a growing demand for both pharmaceutical and contracted manufacturers to adapt to the evolving HPAPI landscape.&#nl&#nlThe event will e…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(96) "
https://www.pharmiweb.com/event/highly-potent-active-pharmaceutical-ingredients                "
  ["blog_url"]=>
  string(96) "
https://www.pharmiweb.com/event/highly-potent-active-pharmaceutical-ingredients                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2344"
  ["article_id"]=>
  string(4) "2344"
  [1]=>
  string(55) "9th World Congress on Biopolymers and Polymer Chemistry"
  ["article_title"]=>
  string(55) "9th World Congress on Biopolymers and Polymer Chemistry"
  [2]=>
  string(150) "Biopolymers and polymer chemistry 2019 World congress is an attempt to explore the various ways to utilize natural resources for betterment of the fut"
  ["short_description"]=>
  string(150) "Biopolymers and polymer chemistry 2019 World congress is an attempt to explore the various ways to utilize natural resources for betterment of the fut"
  [3]=>
  string(512) "Biopolymers and polymer chemistry 2019 World congress is an attempt to explore the various ways to utilize natural resources for betterment of the future, promising a better tomorrow for the progeny and a better vision for the springing research. Polymer chemistry and Biopolymers conferences is anticipated to be one of the best scientific conferences in Asia and Australia. This session presents the Biodegradable plastics (Bio plastics) are one of the important issues in plastic industry. These a…"
  ["description"]=>
  string(512) "Biopolymers and polymer chemistry 2019 World congress is an attempt to explore the various ways to utilize natural resources for betterment of the future, promising a better tomorrow for the progeny and a better vision for the springing research. Polymer chemistry and Biopolymers conferences is anticipated to be one of the best scientific conferences in Asia and Australia. This session presents the Biodegradable plastics (Bio plastics) are one of the important issues in plastic industry. These a…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(104) "
https://www.pharmiweb.com/event/9th-world-congress-on-biopolymers-and-polymer-chemistry                "
  ["blog_url"]=>
  string(104) "
https://www.pharmiweb.com/event/9th-world-congress-on-biopolymers-and-polymer-chemistry                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2343"
  ["article_id"]=>
  string(4) "2343"
  [1]=>
  string(54) "16th World Congress on Industrial Pharma and Marketing"
  ["article_title"]=>
  string(54) "16th World Congress on Industrial Pharma and Marketing"
  [2]=>
  string(158) "We are honored and delighted to welcome you to attend “16th World Congress on Industrial Pharma and Marketing” to be held in beautiful "city "
  ["short_description"]=>
  string(158) "We are honored and delighted to welcome you to attend “16th World Congress on Industrial Pharma and Marketing” to be held in beautiful "city "
  [3]=>
  string(554) "We are honored and delighted to welcome you to attend “16th World Congress on Industrial Pharma and Marketing” to be held in beautiful "city of lights" at Paris, France during May 13-14, 2019. The projected theme of the conference is “Transforming technology and its usage in pharmaceutical industry”.&#nl&#nlOur ambition is to layout the bridge and enhance  a network where our scientists, industry related researchers and contributors of related field can share their ideas, modern day research, t…"
  ["description"]=>
  string(554) "We are honored and delighted to welcome you to attend “16th World Congress on Industrial Pharma and Marketing” to be held in beautiful "city of lights" at Paris, France during May 13-14, 2019. The projected theme of the conference is “Transforming technology and its usage in pharmaceutical industry”.&#nl&#nlOur ambition is to layout the bridge and enhance  a network where our scientists, industry related researchers and contributors of related field can share their ideas, modern day research, t…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(103) "
https://www.pharmiweb.com/event/16th-world-congress-on-industrial-pharma-and-marketing                "
  ["blog_url"]=>
  string(103) "
https://www.pharmiweb.com/event/16th-world-congress-on-industrial-pharma-and-marketing                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2342"
  ["article_id"]=>
  string(4) "2342"
  [1]=>
  string(50) "SMis 19th Annual Pain Therapeutics Conference 2019"
  ["article_title"]=>
  string(50) "SMis 19th Annual Pain Therapeutics Conference 2019"
  [2]=>
  string(156) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected t"
  ["short_description"]=>
  string(156) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected t"
  [3]=>
  string(524) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical pain, arthritis, and fibromyalgia, is driving growth.&#nl&#nlJoin Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of le…"
  ["description"]=>
  string(524) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical pain, arthritis, and fibromyalgia, is driving growth.&#nl&#nlJoin Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of le…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(99) "
https://www.pharmiweb.com/event/smis-19th-annual-pain-therapeutics-conference-2019                "
  ["blog_url"]=>
  string(99) "
https://www.pharmiweb.com/event/smis-19th-annual-pain-therapeutics-conference-2019                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2341"
  ["article_id"]=>
  string(4) "2341"
  [1]=>
  string(63) "SMi’s 19th Annual Pain Therapeutics Conference"
  ["article_title"]=>
  string(63) "SMi’s 19th Annual Pain Therapeutics Conference"
  [2]=>
  string(156) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected t"
  ["short_description"]=>
  string(156) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected t"
  [3]=>
  string(524) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical pain, arthritis, and fibromyalgia, is driving growth.&#nl&#nlJoin Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of le…"
  ["description"]=>
  string(524) "Proudly sponsored by: Lotus Clinical Research and MD Biosciences&#nl&#nlThe global opioids market size was valued at $22.96bn USD in 2016 and is projected to expand at a CAGR of 4.8% between 2018 and 2025. Rising prevalence of diseases that cause chronic pain, such as cancer, lower back pain, post-surgical pain, arthritis, and fibromyalgia, is driving growth.&#nl&#nlJoin Europe's leading Pain Therapeutics Conference, to explore the cutting-edge research of novel therapeutic targets in the pipeline of le…"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(99) "
https://www.pharmiweb.com/event/smiâ-s-19th-annual-pain-therapeutics-conference                "
  ["blog_url"]=>
  string(99) "
https://www.pharmiweb.com/event/smiâ-s-19th-annual-pain-therapeutics-conference                "
  [15]=>
  string(19) "1970-01-01 07:30:00"
  ["add_date"]=>
  string(19) "1970-01-01 07:30:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:54"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:54"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}